Evidence map›Paper›PMID 39891097›Full record

SynthesisBMC urology2025

Risk factors for renal insufficiency and survival implications after radical nephrectomy and thrombectomy in renal cell carcinoma with tumor thrombus: a systematic review.

Zhigao Huang, Zhuo Liu, Lin Zhuo, Xin Ma, Zhenbin Jiang, Kewei Chen, Jiyuan Chen, Yuxuan Li, Guoliang Wang, Xiaojun Tian and 5 more

Abstract readSystematic Review
In one paragraph

Synthesis in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. [Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhigao Huang *Department of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Zhuo Liu *Department of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Lin Zhuo *Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Xin MaDepartment of Urology, Tongxin People's Hospital, Tongxin, 751300, Ningxia, P.R. China.
Zhenbin JiangDepartment of Nephrology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Kewei ChenDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Jiyuan ChenDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Yuxuan LiDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Guoliang WangDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Xiaojun TianDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Hongxian ZhangDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Lei LiuDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Lulin MaDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China.
Kai HongDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China. kenhong99@bjmu.edu.cn.
Shudong ZhangDepartment of Urology, Peking University Third Hospital, Beijing, 100191, P.R. China. zhangshudong@bjmu.edu.cn.

Funding

Peking University Third Hospital clinical key project BYSYZD2023035
6 · The paper itself

Abstract

backgroundRenal cell carcinoma (RCC) with venous tumor thrombus (VTT) is great burden over world. Radical nephrectomy (RN) with thrombectomy seems to be its gold standard operation, which might cause reduction of renal function. The aim of this systematic review was to provide evidence about the incidence, risk factors, possible reasons and influence of renal insufficiency in RCC patients undergoing RN with thrombectomy.

methodsA systematic search using PubMed, Embase, Web of Science, the Cochrane Library and European Urology databases was conducted. Study selection followed the PRISMA guidelines. After screening, eleven articles and abstracted fully compatible with the PICOS were included in this systematic review. The study was registered with PROSPERO, CRD42024516596.

resultsOverall, a total of 1,668 patients who were diagnosed with RCC and VTT and underwent RN (open/laparoscopic/robotic) with thrombectomy were analyzed. The postoperative renal insufficiency was present from 0.7 to 53.9%. Relevant risk factors of postoperative renal insufficiency could be summarized into three aspects: baseline characteristics (male gender, tumor thrombus level), intraoperative procedure (surgical method and inferior vena cava clamping time) and other factors (development of the times). The reason of renal insufficiency could be depletion of circulation volume, alteration in renal hemodynamics and condition of solitary kidney. The overall survival (OS) ranged from 2 months to 98 months. A clear association between survival and renal function could not be established because of the oncological risk on survival. Necessary managements like supplying blood volume, diuretic therapy and renal replacement therapy should be applied.

conclusionsThe present incidence of postoperative renal insufficiency was underestimated. More possible risk factors should be explored. Large cohort, multi-center, prospective, and well-designed studies would be necessary to corroborate these results and provide high-grade recommendation for clinical practice.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsNephrectomyPostoperative ComplicationsRenal InsufficiencyThrombectomyHumansRisk FactorsSurvival RatePostoperative renal insufficiencyRadical nephrectomyRenal cell carcinomaRisk factorsSurvival implicationsThrombectomyTumor thrombus

Identifiers

PMID39891097
PMCPMC11783759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.